Results 191 to 200 of about 145,853 (310)
471 ISOLATED INTESTINAL BILE ACID (BA) MALABSORPTION, A CAUSE OF CHRONIC DIARRHEA [PDF]
Judith M. Sondheimer +4 more
openalex +1 more source
Betaine supplementation improved growth performance, nutrient digestibility, blood lipid profiles and caecal lesion scores in broilers experimentally challenged with coccidiosis, with the greatest benefits observed at 600 mg/kg, highlighting its potential as a supportive dietary strategy against coccidial infection. ABSTRACT The objective of this study
Abdul Hafeez +6 more
wiley +1 more source
Idiopathic Duodenocolic Fistula Presenting as Chronic Diarrhea: Successful Surgical Management After Failed Endoscopic Closure. [PDF]
Vieira B, Monteiro A, Pinto-de-Sousa J.
europepmc +1 more source
Delayed small-intestinal transit in tropical malabsorption. [PDF]
Gordon Cook
openalex +1 more source
Cremation weights for an Italian contemporary sample
Abstract The increased demand for the study of cremated remains, combined with their poor state of preservation, presents anthropologists with highly complex and challenging cases. In this context, cremains weight is considered a stable parameter, not influenced by the fragmentation state of the remains, useful in anthropological investigations ...
Barbara Bertoglio +7 more
wiley +1 more source
Malnutrition and Sarcopenia in Patients with Neuroendocrine Tumors: A Comprehensive Review of Evidence. [PDF]
Poulia KA +5 more
europepmc +1 more source
Nine out of ten inpatients treated for various types of substance use disorders had a Vitamin D deficiency. Vitamin D deficiency was associated with lower calcium plasma levels, higher BMI and craving levels for both substance and food. Vitamin D supplementation should be part of the treatment regimen of people with substance use disorders.
Luca Pavirani +5 more
wiley +1 more source
Upper gut bacterial overgrowth is a potential mechanism for Glucose Malabsorption after Vertical Sleeve Gastrectomy [PDF]
Timothy R. Koch
openalex +1 more source
Abstract Aims Semaglutide, a GLP‐1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg).
Mathieu Alissou +18 more
wiley +1 more source

